(Q55078934)

17 June 2018

5 references

13 March 2019

24 March 2019

6 October 2019

12 November 2019

16 July 2021

0 references

Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: A systematic review and meta-analysis. (English)

1 reference

17 June 2018

human musculoskeletal system

4 references

13 March 2019

24 March 2019

6 October 2019

12 November 2019

1 reference

organic compound, having C-P covalent bound

6 October 2019

1 reference

bone density conservation agents

12 November 2019

1 reference

16 July 2021

Liang Ren

1

1 reference

17 June 2018

Weidong Wang

series ordinal

2

1 reference

17 June 2018

language of work or name

English

0 references

publication date

1 April 2018

6 references

17 June 2018

13 March 2019

24 March 2019

6 October 2019

12 November 2019

16 July 2021

6 references

17 June 2018

13 March 2019

24 March 2019

6 October 2019

12 November 2019

16 July 2021

97

1 reference

17 June 2018

page(s)

e0379

1 reference

17 June 2018

issue

17

1 reference

17 June 2018

Creative Commons Attribution-NonCommercial 4.0 International

copyright license

5 references

13 March 2019

24 March 2019

6 October 2019

12 November 2019

on focus list of Wikimedia project

16 July 2021

ScienceSource

0 references

cites work

Long-term use of bisphosphonates in osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Prevalence of Severe Joint Pain Among Adults with Doctor-Diagnosed Arthritis - United States, 2002-2014.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Bisphosphonates for steroid-induced osteoporosis.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

The 21- to 27-year results of the Harris-Galante cementless total hip arthroplasty

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Perioperative alendronate, risedronate, calcitonin and indomethacin treatment alters femoral stem fixation and periprosthetic bone mineral density in ovariectomized rats

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Long-term clinical consequences of stress-shielding after total hip arthroplasty without cement

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Periprosthetic bone remodeling of short cementless femoral stems in primary total hip arthroplasty: A systematic review and meta-analysis of randomized-controlled trials.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: A meta-analysis from randomized controlled trails.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Periprosthetic Bone Remodeling After Novel Short-Stem Neck-Sparing Total Hip Arthroplasty.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Risedronate does not enhance fixation or BMD in revision cups: randomised study with three years follow-up

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

How effective is risedronate in preventing bone loss in patients on high-dose steroids?

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5944478

Risedronate: a new oral bisphosphonate

13 August 2018

1 reference

12 December 2020

Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty

1 reference

12 December 2020

Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study

1 reference

12 December 2020

Clinical efficacy of oral risedronate therapy in Japanese patients with Paget's disease of bone

1 reference

12 December 2020

Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?

1 reference

12 December 2020

Do Stem Design and Surgical Approach Influence Early Aseptic Loosening in Cementless THA?

1 reference

12 December 2020

10.1097/MD.0000000000010379

Identifiers

DOI

1 reference

17 June 2018

PMCID

5944478

1 reference

17 June 2018

PubMed ID

29702983

1 reference

17 June 2018